The trial has missed its primary goal, denting the prospects of a molecule analysts tipped to yield...
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
The trial has missed its primary goal, denting the prospects of a molecule analysts tipped to yield blockbuster sales and diversify Novo's portfolio.
Author: Fierce Biotech
Read Original Article